The synergistic therapy combining Cu2-xSe/ZIF-8 nanoparticles with crizotinib for the treatment of colorectal cancer
Colloid and Interface Science Communications · 2026-05 · 72 · 100890
DOI: 10.1016/j.colcom.2026.100890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloid and Interface Science Communications, 2026-05. Verfasst von Long Xu und 12 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Medical Research Foundation, Shenzhen Science and Technology Innovation Committee.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Guangdong Medical Research Foundation
- Shenzhen Science and Technology Innovation Committee
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Xu, L., Zhang, M., Peng, Z., Zhu, M., Ma, Q., Qian, Y., Yang, G., Zheng, X., Liu, Z., Meng, Y., Zhang, Z., Peng, Y., & Zhang, Y. (2026). The synergistic therapy combining Cu2-xSe/ZIF-8 nanoparticles with crizotinib for the treatment of colorectal cancer. Colloid and Interface Science Communications, 72, 100890. https://doi.org/10.1016/j.colcom.2026.100890
Vancouver
Xu L, Zhang M, Peng Z, Zhu M, Ma Q, Qian Y, et al. The synergistic therapy combining Cu2-xSe/ZIF-8 nanoparticles with crizotinib for the treatment of colorectal cancer. Colloid and Interface Science Communications. 2026;72:100890. doi:10.1016/j.colcom.2026.100890
BibTeX
@article{Xu2026,
author = {Xu, Long and Zhang, Mingming and Peng, Zheng and Zhu, Mengni and Ma, Qin and Qian, Yun and Yang, Gongli and Zheng, Xiaoli and Liu, Zhenyu and Meng, Yu and Zhang, Zhili and Peng, Yao and Zhang, Yong},
title = {The synergistic therapy combining Cu2-xSe/ZIF-8 nanoparticles with crizotinib for the treatment of colorectal cancer},
journal = {Colloid and Interface Science Communications},
year = {2026},
volume = {72},
pages = {100890},
doi = {10.1016/j.colcom.2026.100890}
}
EUVIMED